Dental Care Clinics in Pacific Palisades, CA Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Palisades Surgical Arts Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Dr, Suite T4, Pacific Palisades, CA 90272 Phone: 310-459-0014 |
Denstistry By Design Pacific Palisades Dentist Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Dr Apt 205a, Pacific Palisades, CA 90272 Phone: 310-454-0912 Fax: 424-272-9860 |
The Palisades Dentists Dentist Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Dr Ste T2, Pacific Palisades, CA 90272 Phone: 310-459-2303 |
Lynn Watanabe Dds Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Drive, Suite 222, Pacific Palisades, CA 90272 Phone: 310-454-3111 Fax: 310-459-5410 |
Wormser Smiles Dental Office Inc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 910 Via De La Paz, Suite 108, Pacific Palisades, CA 90272 Phone: 310-454-3732 Fax: 310-459-2245 |
David W. Dorfman, Md, Dds, Inc. Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Dr, Suite 204, Pacific Palisades, CA 90272 Phone: 310-857-2088 |
Dr. William Francis D.d.s. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 881 Alma Real Dr, Suite T-2, Pacific Palisades, CA 90272 Phone: 310-459-2303 Fax: 310-459-0015 |
News Archive
Researchers explore how eye muscles retain mobility in ALS patients
Amyotrophic Lateral Sclerosis, commonly known as ALS, is an incurable neurodegenerative disease that affects all voluntary muscles in the body leading to paralysis and breathing difficulties.
House health bill has controversial CHIP provision
The $894 billion health reform bill working its way toward a House vote this week would repeal the Children's Health Insurance Program, shifting some low-income kids into Medicaid and others into private plans that would both cost more and guarantee fewer benefits," The Washington Independent reports.
Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX
Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.
New ultrasound technique can help determine severity of muscle loss in critically ill patients
Researchers have identified a new technique that can help determine the severity of muscle loss in critically ill patients. The breakthrough could lead to new research to help prevent muscle-wasting and new therapeutic interventions to help treat critically ill patients.
23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam
Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all diseases.
› Verified 1 days ago